Celldex Therapeutics (CLDX) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St set to open lower after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| CELLDEX THERAPEUTICS, Inc. (NASDAQ: CLDX) | Delayed: 28.51 -0.46 (1.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.97 | 52 Week High | $18.62 | |||
| Open | $28.42 | 52 Week Low | $2.85 | |||
| Day High | $28.95 | P/E | N/A | |||
| Day Low | $28.41 | EPS | $-1.02 | |||
| Volume | 11,936 | |||||
